Transcriptomic and Clonal Characterization of T Cells in the Human Central Nervous System
Demographics (3)
- AGE - Subject age at enrollment (phv00435713.v2.p1)
- COLLECTION_AGE - Age of subject at collection (phv00435724.v2.p1)
- SEX - Biological sex (phv00435707.v2.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00435712.v2.p1)
Other (17)
- ANALYTE_TYPE - Analyte type (phv00435721.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00435720.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00435706.v2.p1)
- DISEASE_STATUS - Case control status of the subject (phv00435711.v2.p1)
- DISEASE_STATUS - Disease status (phv00435723.v2.p1)
- IS_TUMOR - Tumor status (phv00435722.v2.p1)
- LESION_DESCRIPTION - Description of lesion type for RRMS patients, N/A for controls (phv00435718.v2.p1)
- NEW_DIAGNOSIS - If patient had been diagnosed with relapsing-remitting MS (RRMS) within 12 months of the lumbar puncture (phv00435714.v2.p1)
- OCB_STATUS - Patient's oligoclonal band status at enrollment, N/A for controls (phv00435716.v2.p1)
- RBC_LYSED - If sample was red blood cell lysed (phv00435725.v2.p1)
- SAMPLE_ID - Sample ID (phv00435719.v2.p1)
- SAMPLE_ID - Sample ID (phv00435709.v2.p1)
- SUBJECT_ID - Subject ID (phv00435710.v2.p1)
- SUBJECT_ID - Subject ID (phv00435705.v2.p1)
- SUBJECT_ID - Subject ID (phv00435708.v2.p1)
- TIME_ONSET - Months between first symptoms and lumbar puncture, N/A for controls (phv00435717.v2.p1)
- TIME_SINCE_STEROIDS - Months since patient received steroids; "None" if patient had not received steroids, N/A for controls (phv00435715.v2.p1)